Glaukos Corporation
corporate_fare Company Profile
Glaukos Corporation (NYSE:GKOS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for GKOS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-28, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 8 rated 8 or above. Recent SEC coverage for GKOS spans 10-Q, 8-K, 144, 10-K.
Recent high-impact activity:
- Glaukos 10-Q Confirms Q3 Sales of $211.0M (+58%) and First Quarterly Profit of $2.0M
- Glaukos Beats with $211M Q3 Sales, Raises 2026 Guidance to $775-785M and Sets $1B 2027 Target
- Glaukos Posts $211M in Third-Quarter Sales
- iDose TR Beats Cataract Surgery Alone in Phase 4, Cutting IOP by 3.6 mmHg More
- Insider Sale Sends Glaukos Down 13% Despite Positive Epioxa Data
Financial Snapshot
Short Interest & Short Volume
2.85 days to coverFINRA reported short interest of 4,483,891 shares in GKOS as of the October 30, 2026 settlement, a 3.2% increase from the prior period — about 2.9 days to cover at its recent average daily volume. On November 20, 2026, 46.4% of GKOS volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.